Janux Therapeutics, Inc. Property, Plant & Equipment (PPE)
| Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|
| Property, Plant & Equipment (PPE) | $21.0K | $155.0K | $1,597.0K | $29.4M | $27.8M | $24.2M |
Janux Therapeutics, Inc. (JANX) Property, Plant & Equipment (PPE) comparison analysis
General
LTM Property, Plant & Equipment (PPE)
Growth
Company name
YoY growth
3Y CAGR
5Y CAGR
JANX key stats
| Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|
% growth | 0.0 0.0% | 0.0 0.0% | 3.6 0.0% | 8.6 136.8% | 8.1 (6.1%) | 10.6 31.0% |
| Cost of Goods Sold (COGS) | 0.0 | 0.0 | 0.1 | 0.8 | 2.0 | 0.0 |
% margin | (0.0) 0.0% | (0.0) 0.0% | 3.5 96.9% | 7.8 90.2% | 6.1 75.8% | 10.6 100.0% |
| Operating Expenses | 3.8 | 4.8 | 36.6 | 75.7 | 81.1 | 109.4 |
| Research & Development Expenses (R&D) | 3.0 | 3.0 | 26.2 | 53.4 | 54.9 | 68.4 |
| Selling, General & Administrative Expenses (SG&A) | 0.8 | 1.8 | 10.3 | 22.3 | 26.1 | 41.0 |
% margin | (3.8) 0.0% | (4.8) 0.0% | (32.9) (905.4%) | (67.1) (779.0%) | (73.0) (902.9%) | (98.8) (933.6%) |
| Interest Income | 0.2 | 0.2 | 0.3 | 4.0 | 14.7 | 29.9 |
| Interest Expense | 0.2 | 0.2 | 0.0 | 4.0 | 0.0 | 0.0 |
| Pre-tax Income | (4.0) | (6.8) | (32.7) | (63.1) | (58.3) | (69.0) |
% effective tax rate | 0.2 (5.8%) | (1.5) 22.5% | (0.1) 0.3% | (8.9) 14.1% | 0.0 0.0% | 0.0 0.0% |
% margin | (4.2) 0.0% | (5.3) 0.0% | (32.6) (895.2%) | (54.2) (628.8%) | (58.3) (721.2%) | (69.0) (651.6%) |
| EPS | (0.10) | (0.13) | (0.79) | (1.31) | (1.32) | (1.28) |
| Diluted EPS | (0.10) | (0.13) | (0.79) | (1.31) | (1.32) | (1.28) |
% margin | (3.8) 0.0% | (4.8) 0.0% | (32.8) (902.3%) | (66.3) (769.3%) | (71.0) (878.7%) | (98.8) (933.6%) |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
FAQ
1) What is Janux Therapeutics, Inc.'s Property, Plant & Equipment (PPE)?
As of today, Janux Therapeutics, Inc.'s last 12-month Property, Plant & Equipment (PPE) is $24.2M, based on the financial report for Dec 31, 2024 (Q4’2024).
2) What is Janux Therapeutics, Inc.'s Property, Plant & Equipment (PPE) growth rate?
Over the last year, Janux Therapeutics, Inc.'s Property, Plant & Equipment (PPE) growth was (13.3%). The average annual Property, Plant & Equipment (PPE) growth rates for Janux Therapeutics, Inc. have been 382.5% over the past three years, N/A over the past five years.
3) Is Janux Therapeutics, Inc.'s Property, Plant & Equipment (PPE) growth rate Good?
Over the last year, Janux Therapeutics, Inc.'s Property, Plant & Equipment (PPE) growth was (13.3%), which is lower than industry growth of (0.2%). It indicates that Janux Therapeutics, Inc.'s Property, Plant & Equipment (PPE) growth is Good.